NYLI WMC Value Class A (MAPAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
30.27
-0.13 (-0.43%)
Jun 25, 2025, 4:00 PM EDT
3.52% (1Y)
Fund Assets | 1.03B |
Expense Ratio | 1.10% |
Min. Investment | $15,000 |
Turnover | n/a |
Dividend (ttm) | 1.57 |
Dividend Yield | 4.88% |
Dividend Growth | 24.45% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 9, 2024 |
Previous Close | 30.40 |
YTD Return | 9.76% |
1-Year Return | 15.68% |
5-Year Return | 101.83% |
52-Week Low | 26.86 |
52-Week High | 32.94 |
Beta (5Y) | n/a |
Holdings | 68 |
Inception Date | Jan 21, 1971 |
About MAPAX
The NYLI WMC Value Class A (MAPAX) seeks to earn income as a secondary objective. MAPAX normally invests at least 65% of its total assets in equity-type securities.
Fund Family MainStay Fds A
Category Large Value
Stock Exchange NASDAQ
Ticker Symbol MAPAX
Share Class Class A
Index Russell 1000 Value NR
Performance
MAPAX had a total return of 15.68% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.44%.
Top 10 Holdings
23.86% of assetsName | Symbol | Weight |
---|---|---|
JPMorgan Chase & Co. | JPM | 3.93% |
Johnson & Johnson | JNJ | 3.23% |
UnitedHealth Group Incorporated | UNH | 2.73% |
Cisco Systems, Inc. | CSCO | 2.37% |
Gilead Sciences, Inc. | GILD | 2.09% |
American International Group, Inc. | AIG | 2.07% |
Pfizer Inc. | PFE | 1.94% |
Johnson Controls International plc | JCI | 1.86% |
Elevance Health, Inc. | ELV | 1.86% |
Marsh & McLennan Companies, Inc. | MMC | 1.78% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 9, 2024 | $1.57019 | Dec 9, 2024 |
Dec 6, 2023 | $1.26168 | Dec 6, 2023 |
Dec 7, 2022 | $1.58752 | Dec 7, 2022 |
Dec 2, 2021 | $25.77691 | Dec 2, 2021 |
Dec 2, 2020 | $1.67369 | Dec 2, 2020 |
Dec 2, 2019 | $3.50589 | Dec 2, 2019 |